NEUSOFT XIKANG HOLDINGS INC. (HK:9686)
:9686
Want to see HK:9686 full AI Analyst Report?
9686 Stock Chart & Stats
HK$0.90
HK$0.07(8.97%)
At close: 4:00 PM EST
HK$0.90
HK$0.07(8.97%)
Day’s Range― - ―
52-Week RangeHK$0.75 - HK$1.16
Previous CloseN/A
Volume78.50K
Average Volume (3M)60.92K
Market Cap
HK$841.88M
Enterprise ValueHK$749.96M
Total Cash (Recent Filing)HK$703.42M
Total Debt (Recent Filing)HK$520.84M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding841,876,830
10 Day Avg. Volume65,850
30 Day Avg. Volume60,916
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)2.17
Price to Sales (P/S)1.47
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Operating Cash FlowOperating cash flow reversal to positive in 2024 and further improvement in 2025 signals a structural improvement in cash generation versus prior years. Sustained positive OCF reduces reliance on external financing, supports working capital and gives management scope to fund operations or modest reinvestment without depending on equity issuance.
Balance-sheet Repair (equity Now Positive)Restoration of positive equity after prior negative periods indicates progress repairing the balance sheet. A positive equity base improves solvency metrics, enhances creditor confidence, and provides a longer-term cushion against shocks, enabling more strategic flexibility for restructuring or targeted investment if operating trends stabilize.
Narrowing Operating LossesMaterial narrowing of operating losses relative to 2021–2023 reflects improving cost control or higher-margin activity, indicating a trajectory toward break-even. If this trend persists, fixed-cost absorption and margin expansion become achievable, improving the likelihood of sustainable profitability over the medium term.
Bears Say
Contracting RevenueTwo consecutive years of revenue decline reduce operating leverage and make it harder to convert gross profit into operating income. Continued top-line contraction undermines margin recovery, constrains reinvestment capacity and increases reliance on cost cuts to achieve profitability, a fragile path for sustainable growth.
Meaningful LeverageDebt materially exceeding equity at a ~1.58 D/E ratio raises refinancing and solvency risk if cash flows weaken. High leverage limits financial flexibility for R&D, M&A or marketing, increases interest burden and elevates downside risk during cyclical stress, making recovery more dependent on consistent cash generation.
Volatile Free Cash FlowSwinging FCF from positive to breakeven indicates uneven ability to convert operating cash into discretionary funds. That volatility constrains capacity to deleverage, invest in growth, or absorb shocks. Even with improving OCF, inconsistent FCF limits durable reinvestment and raises execution risk for returning to sustained growth.
NEUSOFT XIKANG HOLDINGS INC. News
9686 FAQ
What was NEUSOFT XIKANG HOLDINGS INC.’s price range in the past 12 months?
NEUSOFT XIKANG HOLDINGS INC. lowest stock price was HK$0.75 and its highest was HK$1.16 in the past 12 months.
What is NEUSOFT XIKANG HOLDINGS INC.’s market cap?
NEUSOFT XIKANG HOLDINGS INC.’s market cap is HK$841.88M.
When is NEUSOFT XIKANG HOLDINGS INC.’s upcoming earnings report date?
NEUSOFT XIKANG HOLDINGS INC.’s upcoming earnings report date is Aug 27, 2026 which is in 81 days.
How were NEUSOFT XIKANG HOLDINGS INC.’s earnings last quarter?
NEUSOFT XIKANG HOLDINGS INC. released its earnings results on Mar 19, 2026. The company reported HK$0.013 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.013.
Is NEUSOFT XIKANG HOLDINGS INC. overvalued?
According to Wall Street analysts NEUSOFT XIKANG HOLDINGS INC.’s price is currently Overvalued.
Does NEUSOFT XIKANG HOLDINGS INC. pay dividends?
NEUSOFT XIKANG HOLDINGS INC. does not currently pay dividends.
What is NEUSOFT XIKANG HOLDINGS INC.’s EPS estimate?
NEUSOFT XIKANG HOLDINGS INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NEUSOFT XIKANG HOLDINGS INC. have?
NEUSOFT XIKANG HOLDINGS INC. has 841,876,830 shares outstanding.
What happened to NEUSOFT XIKANG HOLDINGS INC.’s price movement after its last earnings report?
NEUSOFT XIKANG HOLDINGS INC. reported an EPS of HK$0.013 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of NEUSOFT XIKANG HOLDINGS INC.?
Currently, no hedge funds are holding shares in HK:9686
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
NEUSOFT XIKANG HOLDINGS INC. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.00%
12-Months-Change
Fundamentals
Return on Equity
-11.58%
Trailing 12-Months
Asset Growth
-5.26%
Trailing 12-Months
Company Description
NEUSOFT XIKANG HOLDINGS INC.
Xikang Cloud Hospital Holdings, Inc. engages in the development of a city-specific cloud hospital platform. It operates through the following segments: Cloud Hospital Platform Services, Internet Medical Services, Health Management Services, and Smart Healthcare Products. The Cloud Hospital Platform Services segment offers technology solutions to local governments, medical institutions, and insurers. The Internet Medical Services segment includes online hospital, remote medical, smart family doctor, and internet home care services. The Health Management Services segment consists of comprehensive health management and chronic disease management services. The Smart Healthcare Products segment sells smart healthcare products to local governments, primary medical institutions, corporations, and individuals. The company was founded on May 12, 2011 and is headquartered in Shanghai, China.
Technical Analysis
Yidu Tech, Inc.
―
MicroPort CardioFlow Medtech Corp.
―
Suzhou Basecare Medical Corp. Ltd. Class H
―
Beijing Airdoc Technology Co. Ltd. Class H
―
Shanghai Conant Optical Co. Ltd. Class H
―